METHOD FOR DETERMINING therapeutic efficacy of plasmapheresis in hemolytic disease of newborn

摘要

method u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 curative effectiveness in hemolytic disease of newborn u043fu043bu0430u0437u043cu0430u0444u0435u0440u0435u0437u0430, including the definition of reserve u0441u0432u00a0u0437u044bu0432u0430u043du0438u00a0 albumin, remember u0449u0438u0439u0441u00a0 because he u043eu043fu0440u0435u0434u0435u043bu00a0u0435u0442u0441u00a0 in blood after each session u043fu0440u043eu0432u0435u0434u0435u043du0438u00a0 u043fu043bu0430u0437u043cu0430u0444u0435u0440u0435u0437u0430 and if its rate of 10.0 g / l and above, u0441u0447u0438u0442u0430u0435u0442u0441u00a0 appropriate. u0435u0434u0443u044eu0449u0435u0433u043e session u043fu043bu0430u0437u043cu0430u0444u0435u0440u0435u0437u0430 and below or equal to 10.0 g / l - with regard.